Xealth adds Atrium Health, Cleveland Clinic and MemorialCare to close $14m Series A
Xealth, the leading platform for connecting digital health, today announced that it has secured an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. Investments from this round will be used to advance the development and deployment of the Xealth platform for digital health programs.
Catapult, Prevent Biometrics Partner to Sync Safety, Performance Data
In conducting extensive trials with college and high school sports teams, Prevent Biometrics found value in syncing the impact data gleaned from its smart mouthguards with game video to provide context on collisions.
TMAO and Heart Disease: The New Red Meat Risk?
Over the past several decades, public health experts and physicians have pinned a hefty portion of the blame for heart disease on saturated fat. That’s not without reason. The long-chain saturated fatty acids found in foods like steak, butter, and coconut oil raise artery-clogging low–density lipoprotein (LDL) cholesterol, a cause of atherosclerotic cardiovascular disease. At the same time, diets high in red meat have been strongly associated with heart disease and mortality.
Hospitals look to computers to predict patient emergencies before they happen
Seven floors, and long odds, were stacked against John S. He was undergoing a test on the first floor of a Cleveland Clinic hospital when his nursing team — on the eighth floor — got a call, telling them the 57-year-old had developed a dangerously rapid heartbeat that was spiraling toward cardiac arrest.
Cleveland Diagnostics Announces Publication of Multicenter IsoPSA Clinical Validation Study Demonstrating Improved Accuracy Over Prostate-Specific Antigen Test
Cleveland Diagnostics, Inc., a clinical-stage company focused on developing next-generation diagnostic tests for the detection of cancers, today announced the online publication of results from a multicenter validation study of IsoPSA™, a novel structure-based prostate cancer assay, in Journal of Urology. The study validated the findings from a preliminary study published earlier in European Urology, demonstrating that the non-invasive, blood-based IsoPSA assay has superior diagnostic accuracy over the current gold standard, prostate-specific antigen (PSA), in detecting high-grade prostate cancer.
'They've given me hope': NE Ohio design teams create solutions for disabled veterans
Tables at the Joseph and Helen Lowe Institute for Innovation were strewn with laptop computers, cell phones, electronics and cables.
The surrounding walls were covered with scientific graffiti in drawings, notes and questions to be answered.
It was the stuff of creativity and inspiration, all of it needed to help make the lives of seven disabled veterans a bit easier.
Why Cleveland Clinic is partnering with a manufacturer known for ecommerce
Proto Labs and Cleveland Clinic are jointly developing an awards program to help move novel healthcare ideas forward, says Proto Labs CEO Vicki Holt. The new initiative will be part of Proto Labs’ Cool Idea Award program and will work with Cleveland Clinic Innovations, which says it has executed over 500 licenses and created 75 spin-off companies that have raised over $1 billion in equity investment and commercialization grants since 2000.
Cleveland Clinic, Kent State University and two Cleveland-area companies land Third Frontier grants
Cleveland Clinic and Kent State University both received grants from the Third Frontier's Technology Validation and Start-up Fund, which provides grants to higher education and other nonprofit research institutions "to demonstrate that a technology is commercially viable through activities such as testing and prototyping," with the ultimate goal of licensing the technology to companies.
Protolabs partners with Cleveland Clinic Healthcare Innovations Alliance
Protolabs has forged a partnership with the Cleveland Clinic Healthcare Innovations Alliance to create an awards program that will accelerate healthcare ideas.
Protolabs teams up with Cleveland Clinic to bring ‘cool ideas’ to medtech market
Digital manufacturing company Protolabs (Maple Plain, MN) has teamed up with the Cleveland Clinic Healthcare Innovation Alliance to help bring novel healthcare ideas to fruition. Part of Protolabs' Cool Idea Award program, the winning submissions will receive in-kind manufacturing services from Protolabs to support development and eventual commercialization of the products.